EntryPoint Capital’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-851
Closed -$242K 882
2025
Q4
$242K Hold
851
0.09% 462
2025
Q3
$263K Buy
+851
New +$267K 0.1% 424
2024
Q2
Sell
-571
Closed -$97.9K 1464
2024
Q1
$97.9K Buy
+571
New +$106K 0.09% 434

Other funds holding PODD

EntryPoint Capital's PODD Position: Q1 2026 in Review

EntryPoint Capital sold out of Insulet (PODD) in Q1 2026, closing a stake of 851 shares — an estimated $242K sold.

EntryPoint Capital first reported a position in PODD in Q1 2024 and held it in 3 quarters. The position peaked at $263K in Q3 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • EntryPoint Capital reported no remaining Insulet position as of Q1 2026 after selling out during the quarter.
  • EntryPoint Capital sold 851 Insulet shares in Q1 2026, an estimated $242K.
  • EntryPoint Capital first reported a position in Insulet in Q1 2024 and held it in 3 quarters.
  • EntryPoint Capital's Insulet position peaked at $263K in Q3 2025.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on EntryPoint Capital's 13F filing for Q1 2026, filed 14 May 2026.